The co-expression of CD34 and Prox-1 may support this concept but might suggest an incomplete or heterogeneous switch from mesenchymal to endothelial cells, where heterogeneous protein expression phenotypes may derive from unique and, to date, undefined microenvironmental determinants in KS tumors. This evidence concerns the gene CD34 and Kaposi's sarcoma.